Laboratory Findings in Different Disease Status of COVID-19 Admitted Patients at Dilla University Referral Hospital Treatment Center, South Ethiopia

References

• World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Braz J Implantol Health Sci. 2020;2(3):620–632.
   Google Scholar
• Abdool Karim SS, de Oliveira T, Loots G. Appropriate names for COVID-19 variants. Science. 2021;371(6535):1215.
   PubMed Web of Science ®Google Scholar
• Parums DV. Revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2. Med Sci Monit. 2021;27:e933622–1.
   Web of Science ®Google Scholar
• Del Rio C, Omer SB, Malani PN. Winter of Omicron—the evolving COVID-19 pandemic. JAMA. 2022;327(4):319–320.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kwatra G, Myers JE, et al. Population immunity and Covid-19 severity with Omicron variant in South Africa. N Engl J Med. 2022;386:1314–1326.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu S, Wu B, et al. SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct Target Ther. 2021;6(1):1–3.
   PubMed Web of Science ®Google Scholar
• WHO report. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed August 3, 2022.
   Google Scholar
• WHO report. Available from: https://covid19.who.int/. Accessed August 3, 2022.
   Google Scholar
• Alene KA, Gelaw YA, Fetene DM, et al. COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death. BMJ Open. 2021;11(2):e044606.
   Web of Science ®Google Scholar
• Snider B, Patel B, McBean E. Asymptomatic cases, the hidden challenge in predicting COVID-19 caseload increases. Infect Dis Rep. 2021;13(2):340–347.
   PubMed Web of Science ®Google Scholar
• Leulseged TW, Maru EH, Hassen IS, et al. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study. Pan Afr Med J. 2021;38:351.
   PubMed Web of Science ®Google Scholar
• Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428–442.
   PubMed Web of Science ®Google Scholar
• Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database Syst Rev. 2021;(2). doi:10.1002/14651858.cd013665
   Web of Science ®Google Scholar
• NIH COVID Treatment guidelines: clinical spectrum of SARS-CoV-2 infection. 2021.
   Google Scholar
• Health NIo. Clinical spectrum of SARS-CoV-2 infection. Retrieved April. 2021;12:2021.
   Google Scholar
• Efrati S, Catalogna M, Abu Hamed R, et al. Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients. Sci Rep. 2021;11(1):1–9.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Nielsen TB, Casadevall A. Antibodies, immunity, and COVID-19. JAMA Intern Med. 2021;181(4):460–462.
   Web of Science ®Google Scholar
• World Health Organization. COVID-19 Natural Immunity: Scientific Brief, 10 May 2021. World Health Organization; 2021.
   Google Scholar
• Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(9):529–536.
   PubMed Web of Science ®Google Scholar
• Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID-19. Sci Immunol. 2020;5(53):eabe8063.
   PubMed Web of Science ®Google Scholar
• WHO. What We Know About the COVID-19 Immune Response. WHO; 2020.
   Google Scholar
• Iwasaki A. What reinfections mean for COVID-19. Lancet Infect Dis. 2021;21(1):3–5.
   PubMed Web of Science ®Google Scholar
• Prevost J, Finzi A. The great escape? SARS-CoV-2 variants evading neutralizing responses. Cell Host Microbe. 2021;29(3):322–324.
   PubMed Web of Science ®Google Scholar
• Jabbari P, Rezaei N. With risk of reinfection, is COVID-19 here to stay? Disaster Med Public Health Prep. 2020;14(4):e33–e.
   Web of Science ®Google Scholar
• West J, Everden S, Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Northfield Il). 2021;21(1):e52.
   PubMed Web of Science ®Google Scholar
• Benoni R, Campagna I, Panunzi S, et al. Estimating COVID-19 recovery time in a cohort of Italian healthcare workers who underwent surveillance swab testing. Public Health. 2021;196:52e8.
   Web of Science ®Google Scholar
• An X-S, Li X-Y, Shang F-T, et al. Clinical characteristics and blood test results in COVID-19 patients. Ann Clin Lab Sci. 2020;50(3):299–307.
   Web of Science ®Google Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–e12.
   Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):1–3.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu S, Liu H, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73(4):807–816.
   PubMed Web of Science ®Google Scholar
• Cotton DM, Liu L, Vinson DR, et al. Clinical characteristics of COVID‐19 patients evaluated in the emergency department: a retrospective cohort study of 801 cases. J Am Coll Emerg Physicians Open. 2021;2(4):e12538.
   Google Scholar
• Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1–12.
   Web of Science ®Google Scholar
• Middleton EA, He X-Y, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179.
   PubMed Web of Science ®Google Scholar
• Moradi EV, Teimouri A, Rezaee R, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11–14.
   Web of Science ®Google Scholar
• Stegeman I, Ochodo EA, Guleid F, et al. Routine laboratory testing to determine if a patient has COVID‐19. Cochrane Database Syst Rev. 2020;(11). doi:10.1002/14651858.CD013787
   Web of Science ®Google Scholar
• Wang J, Li Q, Yin Y, et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front Immunol. 2020;2020:2063.
   Web of Science ®Google Scholar
• Zhang H-J, Qi G-Q, Gu X, et al. Lymphocyte blood levels that remain low can predict the death of patients with COVID-19. Medicine. 2021;100(28):e26503.
   Web of Science ®Google Scholar
• Wu W, Wang A, Liu M. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   Web of Science ®Google Scholar
• Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028.
   PubMed Web of Science ®Google Scholar
• Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis. Med Clin (Barc). 2020;155(4):143–151.
   PubMed Web of Science ®Google Scholar
• Zong X, Gu Y, Yu H, Li Z, Wang Y. Thrombocytopenia is associated with COVID-19 severity and outcome: an updated meta-analysis of 5637 patients with multiple outcomes. Lab Med. 2021;52(1):10–15.
   Web of Science ®Google Scholar
• Wang L, Cheng X, Dong Q, et al. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients. BMC Infect Dis. 2021;21(1):1–8.
   Web of Science ®Google Scholar
• Layla KN, Yeasmin S, Azad AB, et al. Red blood cell profile in patients with mild, moderate and severe COVID-19. IMC J Med Sci. 2021;15(2):26–31.
   Google Scholar
• Zhao X, Lei Z, Gao F, Xie Q, Jang K, Gong J. The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: a systematic review and meta-analysis. Medicine. 2021;100(4). doi:10.1101/2020.05.03.20089557
   Google Scholar
• Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK. Abnormal liver tests in COVID‐19: a retrospective observational cohort study of 1827 patients in a major US hospital network. Hepatology. 2020;72(4):1169–1176.
   Web of Science ®Google Scholar
• Malik J, Ishaq U, Laique T, et al. Effect of COVID-19 on lipid profile and its correlation with acute phase reactants. medRxiv. 2021. doi:10.1101/2021.04.13.21255142
   Google Scholar
• Liu Y-M, Xie J, Chen -M-M, et al. Kidney function indicators predict adverse outcomes of COVID-19. Med. 2021;2(1):38–48. e2.
   PubMed Web of Science ®Google Scholar
• Chen D, Li X, Song Q, et al. Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Ntwk Open. 2020;3(6):e2011122–e.
   PubMed Web of Science ®Google Scholar
• Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262–265.
   PubMed Web of Science ®Google Scholar
• Alfano G, Ferrari A, Fontana F, et al. Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021;25(4):401–409.
   Web of Science ®Google Scholar
• Zhou X, Chen D, Wang L, et al. Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical. Biosci Rep. 2020;40(12):BSR20202690.
   Web of Science ®Google Scholar
• Mahat RK, Rathore V, Singh N, et al. Lipid profile as an indicator of COVID-19 severity: a systematic review and meta-analysis. Clin Nutr ESPEN. 2021;45:91–101.
   Web of Science ®Google Scholar